Dopa-responsive dystonia
Dopa-responsive dystonia is a movement disorder characterized by involuntary muscle contractions that typically show significant improvement with L-Dopa medication.
Overview
Dopa-responsive dystonia involves involuntary muscle contractions, tremors, and other uncontrolled movements. Symptoms range from mild to severe and often exhibit diurnal fluctuation, meaning movement problems worsen later in the day and improve in the morning after sleep.
Symptoms
- Early signs: Typically appearing around age 6, symptoms often begin with inward- and upward-turning feet and dystonia in the lower limbs.
- Progression: Dystonia may spread to the upper limbs, eventually involving the whole body by adolescence.
- Parkinsonism: Over time, affected individuals may develop slow movement (bradykinesia), muscle rigidity, tremors, and postural instability.
- Associated issues: Some individuals experience sleep problems or depression, likely due to serotonin disruption.
Causes
The condition is most commonly caused by mutations in the GCH1 gene, though mutations in the TH or SPR genes can also be responsible. These genes are involved in the production of tetrahydrobiopterin (BH4) or the enzyme tyrosine hydroxylase, both of which are essential for the synthesis of the neurotransmitters dopamine and serotonin.
A reduction in dopamine interferes with the brain's ability to produce smooth physical movements, leading to dystonia and tremors. Disruption in serotonin production is linked to the sleep and mood disorders observed in some patients.
Inheritance
Inheritance patterns depend on the specific gene involved:
- GCH1 mutations: Inherited in an autosomal dominant pattern. Some individuals with the mutation never develop symptoms (reduced penetrance), and the condition affects females two to four times more often than males.
- TH mutations: Inherited in an autosomal recessive pattern.
- SPR mutations: Can be inherited in either an autosomal recessive or, less commonly, an autosomal dominant pattern.